Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bayhorse Silver Inc V.BHS

Alternate Symbol(s):  BHSIF

Bayhorse Silver Inc. is a junior natural resource company, which is engaged in the acquisition, exploration and development of natural resource properties. The Company has a 100% interest in the Bayhorse Silver Mine, Oregon United States of America. The Bayhorse Silver Mine and the Pegasus Project are 44 kilometers (km) southwest of Hercules Metals’ porphyry copper discovery. The Company also has an option to acquire an 80% interest in the Brandywine Property located in British Columbia, Canada. The Brandywine Property is located near Squamish, British Columbia.


TSXV:BHS - Post by User

Bullboard Posts
Comment by skydiver069on May 26, 2014 12:26pm
212 Views
Post# 22598337

RE:The fact management considered entering the marijuana

RE:The fact management considered entering the marijuanaI'm starting to think it was done so that they could keep the BHS company name near the 'top of the list', and thus, not drowned out by all the biopharma type companies.

Example:  There's somebody claiming on Grand Power Logistics Group Inc (v.gpw) that they will be doing the same thing.  I only recently learned about this company, but biopharma is on a diferent spectrum then their present business model.  If the company had so much present potential, then why aren't they working on building that up and becomming 'top of the list' in their industry?

That said, I'm tempted to pull any orders I have in companies that may want to convert into biopharma businesses.  Simply because it's sounding like their current business model isn't working for them.
Bullboard Posts